Log in or Sign up for Free to view tailored content for your specialty!
Sleep Disorders News
Q&A: Advantages, pitfalls of sleep-monitoring apps, trackers
In September, Apple received marketing clearance from the FDA for its sleep apnea feature within the Health app on the Apple Watch Series 9, Series 10 and Ultra 2, according to an FDA press release.
Chloral hydrate improves symptoms of severe insomnia at 2 weeks
Topline results from the open-label RESTORE trial showed that chloral hydrate improved symptoms of severe insomnia at 14 days in patients for whom previous behavioral and pharmaceutical solutions have failed.
Log in or Sign up for Free to view tailored content for your specialty!
Study: No clear association between pet ownership and brain, heart health
ORLANDO, Fla. — An analysis of a large cohort of individuals enrolled in a continuous, multinational survey found no clear associations between brain and heart health and pet ownership, according to a poster.
Screen use in bed associated with delayed sleep, psychological distress in children, teens
Although screen use before bedtime did not affect sleep onset or duration in children, using screens in bed not only impacted sleep quality but was also associated with cyberbullying and psychological distress, research showed.
Nurse-led cognitive behavioral therapy program reduces insomnia symptoms
A nurse-supported cognitive behavioral therapy intervention for insomnia reduced symptoms and improved sleep outcomes in veterans, results from a randomized study published in JAMA Internal Medicine showed.
Sulthiame decreases breathing pauses during sleep, daytime sleepiness score in OSA
Among patients with obstructive sleep apnea, receipt of sulthiame for 15 weeks reduced breathing pauses during sleep and daytime sleepiness, according to an abstract presented at the European Respiratory Society International Congress.
Early OSA intervention may lead to better outcomes in infants with Down syndrome
For infants with Down syndrome, early intervention to address obstructive sleep apnea may lead to better cognitive and behavioral outcomes at 36 months, according to new research from The Lancet.
Healio wins APEX award for Psychedelics & Alternative Therapies collection
The Healio news staff received an APEX award in the category of Writing/Topics for work on the potential role of psychedelics and alternative therapies for mental health issues and other medical conditions.
Q&A: Brain receptors may present therapeutic target for sleep disturbances in menopause
Currently, cognitive behavioral therapy for insomnia is the gold standard treatment for sleep disturbances associated with menopause, and research is underway to better target neurons responsible for sleep disturbances.
Pitolisant safe, lowers daytime sleepiness in OSA over 1 year
Among adults with obstructive sleep apnea, excessive daytime sleepiness decreased with 1 year of pitolisant treatment, according to results published in CHEST.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read